| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6f2a393689ce47645af45ec6a3cc51d1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_43a72884e25aaecffebe0942132d704f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_37f4922dfb7777b019e504b885211b8e |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-55583 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-39
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-716
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-716
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-39 |
| filingDate |
2011-06-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e092a3a18bc2611dbec7c7275eae3b06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4ac292d6a84afec72ae566727a4ae658
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c65cadbeee46c4f34faed0e63841f4ab
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_19b23ce72bc84d66f32a7dba74dbc942
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cfcb811b2147916440b812486fc9cfff |
| publicationDate |
2013-12-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
KR-20130130674-A |
| titleOfInvention |
New Immune Adjuvant Compounds and Uses thereof |
| abstract |
The present invention relates to cyclic beta glucan compounds and vaccine compositions comprising them for use as immunoadjuvant. The novel adjuvant compounds in particular represent a novel family of dendritic cell activating molecules. |
| priorityDate |
2010-06-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |